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ABSTRACT
Background: This article is an observational experience of robotic surgery in USA by an Indian Obgyn fellow.
Primary objective is to analyze retrospectively peri operative outcomes in stage 2 and 3 Endometriosis treated with
robot assisted laparoscopy. Secondary objective is to report an Indian Obgyn, Physician observer fellows experience
in USA with Robotic surgery.
Methods: 29 women underwent robotic surgery at in the department of gynecology at Doctor‟s hospital, Baptist
health, Miami. Pre-op time, console time, total operative time, blood loss, peri-operative complications noted.
Results: Mean age is 42 ± 8 years with BMI of 26.2 ± 8 kg/m2. Eighteen patients (62%) were age 40 and above.
Twenty patients (69%) presented with chronic pelvic pain. Dyspareunia in 16 (55.2%), bloating in five (17.2%) and
pelvic mass in thirteen (44.8%) Unilateral pelvic mass in nine patients (31 %) and bilateral in four patients (13.8%).
CA 125 levels are elevated in nine patients (31%) and significantly higher with endometriomas (76.1 ± 49.2 U/ml).
38% underwent robot assisted laparoscopic hysterectomy and BSO. 14.8% underwent robot assisted laparoscopic
hysterectomy with Robot (LSO/RSO). Mean operative time 64.7 min. Mean blood loss 40 ml.
Conclusions: Robotic surgery is safe, with minimal blood loss and shorter hospital stay. Alike in the surgical
techniques, though diverse in the work infrastructure and technology, East and West have common scenarios which
can be tackled with exchange of training opportunities. This interchange of knowledge and skills will benefit patients
with increased surgeon‟s efficiency.
Keywords: Endometriosis, Robotic surgery, Surgical outcomes, da vinci, Minimal invasive surgery

INTRODUCTION
Several surgical subspecialties, such as cardiac,
urological, gynecological, and general surgery have
embraced the use of robotic systems. This latest and most
sophisticated innovation in technology has revolutionized
the practice of surgical scenario in gynecology in recent
years.1 Evolution of the technology and training

http://dx.doi.org/10.5455/2320-1770.ijrcog20150236

opportunities in USA have given a definite advantage to
the gynecologists here than the rest of the world.
Fascinated by the fabulous robotic surgeries I came to
USA, from India, to get trained in the advanced
minimally invasive surgical techniques. I was one of the
few International participants authorized to shadow the
doctors with in BHSF facilities including OR cases. This
program is not a sponsored one but the candidates are
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merit listed and those with a passion in the field are
invited. I had the distinct pleasure of being closely
associated with highly skilled robotic surgeons. Though I
did not personally assist any robotic procedures, I had the
opportunity to watch many interesting robotic cases and
even attended two different hospitals due to huge volume
of robotics performed and utilized time in between for
research activities.
The application of robot assisted laparoscopy in the
treatment of Endometriosis was found to have excellent
outcomes. It has been successfully used in the treatment
of endometriosis when compared to classical laparoscopy
(Nezhat et al., 2009).2 Endometriosis has been linked with
chronic pelvic pain, decreased quality of life, and
Infertility.3 This increasingly important condition
continues to attract gynecologists debate worldwide.
METHODS
Peri-operative outcomes were analyzed retrospectively
for the 29 patients with Endometriosis, from Jan 2013 to
May 2013 who presented to the department of
gynecological oncology at Doctor‟s hospital, Baptist
health South Florida, Miami with a combination of
symptoms of pelvic pain, menorrhagia, bloating,
dyspareunia and pelvic mass.
All the patients underwent robotic assisted laparoscopic
surgery by two board certified gynecologic oncologists
and were diagnosed with stage 2 and 3 endometriosis
(Revised ASRM staging). The primary author is closely
associated with both of the surgeons and followed all
patients peri-operatively. Complete notes of the primary
author are meticulously reviewed by all authors of the
study for accuracy. The da Vinci robotic surgical system
(Intuitive Surgical, Sunnyvale, CA) was used on all
patients (Figure 1) ( da Vinci robot).

affiliated to FIU (Florida International University of
Medicine)
Records were reviewed retrospectively for demographics,
BMI, presenting symptoms, CA 125 levels, USG report,
and prior medical and surgical histories. Operative
outcomes have been analyzed for all the cases which
included total operative time, docking time including
robot assembly and disassembly time, estimated blood
loss, duration of hospital stay, intra operative
complications, conversion to laparotomy, post-operative
complications and blood transfusions.
During the study period, 170 robotic surgeries are
performed and among them 20 patients were diagnosed
as stage 2 and 9 patients were diagnosed with stage 3
endometriosis.
Table 1 summarizes the clinical characteristics of the
patients.
Table 1: Clinical characteristics of the patients.
Characteristic
Age, y ± SD
BMI, kg/m2
Symptoms of presentation
Chronic pelvic pain
Dyspareunia
Dysmenorrhea &
menorrhagia
Pelvic mass
Unilateral
Bilateral
Bloating
Previous ovarian surgery
Infertility
Ca 125 levels, U/ml ± SD
High Ca 125 levels

Details
42 ± 8 years
26.2 ± 8 kg/m2
n (%)
20 (68%)
16 (55.2%)
7 (24.1%)
13 (44.8%)
9 (31%)
4 (13.8%)
5 (17.2%)
7 (24.1%)
6 (20.7%)
76.7 ± 52.2
9 (31%)

Both of the operating surgeons performed the staging of
Endometriosis using revised ASRM guidelines. All the
procedures were performed in the OR dedicated to
robotic surgeries with a skilled team.
An efficient team work makes all the difference to have a
smooth ride during the management of a difficult case.
Pre-operative setup

Figure 1: da Vinci robot used in the study.
With more than 600 robotic cases done per year by both
the surgeons, doctors‟ hospital is one of the busiest
robotic gynecological surgical programs in Miami. There
is a strong referral relationship with the community
gynecologists and family physicians. The hospital is

Includes patient timeout protocol, induction of endotracheal anesthesia, patient positioning and testing of
toleration of steep Trendelenburg. The patient prepped
and draped with gel pads underneath for stability. Eggcrater pads were used underneath the arms and legs to
prevent nerve damage.
A Foley catheter is placed followed by insertion of Vcare or Harris-Kronner Uterine Manipulator Injector
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(HUMI) which aid in the visualization of the pelvis
(Figure 2) (V-care uterine manipulator/elevator).

Surgical technique
Robot assisted laparoscopic hysterectomy is performed
after general anesthesia. Steep Trendelenburg position is
used. After the initial laparoscopy with creation of
pneumo peritoneum by Veress needle, robotic video
laparoscope is introduced through initial 12mm supra
umbilical port. Abdomen is explored to see the extent of
endometriosis. Then the two robotic 8 mm trocars and 12
mm assistant trocar in the right lower quadrant is
introduced.
The equipment used for the laparoscopy included a
Ligasure, monopolar and bipolar system. For the robotic
portion, a needle holder, bipolar, and monopolar scissors
are used.

Figure 2: V-care manipulator.
Pre-operative single dose antibiotic is given routinely to
every patient. With the placement of trocars and
establishment of pneumo peritoneum, the patient is ready
for the docking of the da Vinci robotic system
Port sites
Four trocar sites were placed: an initial 12-mm trocar
was placed supra umbilical, two lower lateral, 8-mm in
the right and left quadrants, and a 12-mm trocar in the
right lower quadrant for the assistant to change the
instruments needed during robot usage. Initially
laparoscopy was performed on every case and then
switched to robotic-assisted surgery. Insertion of robotic
3D camera after removal of the laparoscopic camera is
followed by docking of the two robotic arms to the two 8mm trocars.
Whether it is the medial docking of the patient-side
surgical cart, which was placed in the middle, or lateral
docking next to the patient's legs, depends on the choice
of the surgeon. In this study, each surgeon has a specific
preference with one using medial and the other using
lateral docking (Figure 3) (Lateral docking of the draped
Robot).

Figure 3: Lateral docking of the draped Robot.

Surgeon at the console starts to isolate and transect the
infundibulopelvic ligaments and round ligaments. The
ureters are carefully identified with retroperitoneal
dissection. Ligasure is used to coagulate and transect
uterine vessels and ligaments.
Bladder is separated from lower uterine segment with
blunt dissection. With continuous pressure on the uterine
manipulator by the assistant a demarcation of the cervicovaginal junction is seen. Monopolar scissors is used to
perform circumferential colpotomy. The specimen of the
uterus is then removed enbloc with both ovaries trans
vaginally.
All the endometrial lesions seen are removed. Cuff
closure is done with V-loc non-absorbable knotless
barbed suture which reduces operative times. We
routinely used EVICEL® Fibrin Sealant (Human) for
general hemostasis after the procedure.
Excision of endometriomas is done carefully. In cases
with elevated CA125 levels we routinely performed
frozen sections, confirmed with histology and
documented.

Figure 4: Frozen Section in the lab adjacent to the
OR.
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RESULTS
During the study period, 29 patients underwent robotic
assisted laparoscopic procedures for symptomatic
endometriosis. Most of the patients were referred by
family physicians who recommended definitive therapy
for the chronic pelvic pain or recurrent endometriosis.
The mean age of the study group is 42 ± 8 years with
BMI of 26.2 ± 8 kg/m2 (Table 1).

Figure 5: Endometrioma.

Figure 6: Evicel fibrin sealent.

Among them, eighteen patients (62%) were age 40 and
above. Seven (24.1%) patients had previous surgeries like
USO, ovarian cystectomies, endometrioma excisions by
laparoscopy. Twenty patients (69%) presented with
abdominal or chronic pelvic pain and other pre-operative
symptoms were dyspareunia in sixteen (55.2%),
infertility in six (20.7%), menorrhagia and dysmenorrhea
in seven (24.1%) bloating in five (17.2%) and pelvic
mass in thirteen (44.8%) Unilateral pelvic mass is seen
in nine patients (31 %) and bilateral in four patients (13.8
%) co- existing fibroids are seen in seven (24.1%) and
they were referred due to pelvic mass as a chief
complaint. CA 125 levels are elevated in nine patients
(31%). The CA125 concentration was significantly
higher in females with endometriomas (76.1 ± 49.2
U/ml). Intra operative findings showed endometriomas in
seven patients (24.1%). The presence of superficial and
deep endometriotic implants, endometriomas and pelvic
adhesions was documented in Table 2.
Table 2: Endometriosis characteristics intraoperatively.
Characteristic
Endometrioma
Left ovary
Right ovary
Superficial peritoneal endometriosis
Deep peritoneal endometriosis
Adnexal adhesions
<8
8-16
>16

Figure 7: Endo bag for specimen retrieval.
Statistical analysis
We analyzed retrospectively our collected data.
Descriptive analysis of the operative details is done
including, pre-op time, console time, total operative time,
estimated blood loss, intra and post-operative
complications and hospital stay. Analyzed data is
represented as percentage and/or mean ± Standard
Deviation (SD). The time taken between switching from
laparoscopy to robot was measured as assembly time.
The disassembly time was defined as the time taken to
switch from the robot back to laparoscopy to close the
trocar sites.

n%
7 (24.1%)
4 (13.8%)
3 (10.3%)
12 (41.4%)
3 (10.3%)
Nil
20 (69%)
9 (31%)

Revised ASRM classification is used for adhesions calculations.
Stage-I (minimal, 1-5), Stage-II (mild, 6-15), Stage-III
(moderate, 16-40), Stage-IV (severe, >40)

Superficial peritoneal endometriosis is seen in 12
patients. Adenexal adhesions were mild in 20 patients
(69%) and moderate in 9 patients (31%).
One patient (3.4%) had severe endometriosis with
adhesions to the pelvic sidewall visualized during Robot
assisted laparoscopy, and converted to exploratory
laparotomy with total abdominal hysterectomy.
Table 3 shows the different types of robotic- assisted
surgeries performed during the study by both surgeons.
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Table 3: Distribution of Robotic surgeries for
endometriosis.

Name of surgery
Robotic TAH w/- BSO
Robotic TAH w/- RSO
Robotic TAH w/- LSO
Robotic myomectomy & RSO
Robotic TAH, RSO, left ovarian
cystectomy
Robotic BSO
Robotic LSO
Robotic TAH, left ovarian cystectomy
Robotic right ovarian cystectomy
Robot assisted laparoscopy, E-lap, TAH
Total

Number of
Robotic
surgeries
n (%)
11 (37.9%)
2 (6.9%)
2 (6.9%)
1 (3.4%)
1 (3.4%)
2 (6.9%)
3 (10.3%)
2 (6.9%)
4 (13.8%)
1 (3.4%)
29 (100%)

Eleven patients (37.9%) underwent robot assisted
laparoscopic hysterectomy and bilateral salpingooophorectomy. Eight patients (27.6%) underwent robot
assisted laparoscopic hysterectomy with unilateral
(LSO/RSO) salpingo-oophorectomy. One patient (3.4%)
underwent robotic myomectomy and RSO.
Two patients (6.9%) underwent robotic BSO only and
three patients (10.3%) underwent robotic LSO only. Two
patients (6.9%) had ovarian cystectomies with excision of
endometrial implants and removal of the endometriomas.
One patient (3.4%) underwent Robot assisted
laparoscopy, and converted to exploratory laparotomy
and total abdominal hysterectomy due to dense
adhesions. She had prior surgery for ovarian
endometriomas.
Operative summary and results for all cases were
included in Table 4.

Table 4: Operative summary and results.
Case #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
Average of
all cases

68.4
76.9
69.3
64.4
72.2
71.1
68.2
69.1
68.4
65.8
65.6
69.3
67.2
68.1
68.4
64.1
66.6
69.1
66.8
69.2
53.1
69.1
62.2
64.4
53.4
52.1
55.2
45.1
53.1

Console
time
(minutes)
45.3
50.2
56.1
40.3
35.4
35.3
38.2
41.1
46.1
40.2
48.2
46.3
48.7
39.3
45.2
43.7
44.3
35.2
41.2
34.3
28.2
33.3
34.1
29.8
52.1
36.5
25.7
26.1
28.2

64.7

39.6

Pre-operative
time (minutes)

113.7
127.1
125.4
104.7
107.6
106.4
106.4
110.2
114.5
106
113.8
115.6
115.9
107.4
113.6
107.8
110.9
104.3
108
103.5
81.3
102.4
96.3
94.2
105.5
88.6
80.9
71.2
75.2

Blood
loss
(ml)
45
45
45
30
45
50
50
50
30
50
50
50
50
40
40
45
45
30
30
30
30
40
40
30
50
30
30
40
30

104.1

40.3

Total operative
time (minutes)
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Intra and postoperative
complications
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
Fever
none
none
UTI
none
none
none
none
none
none
none

Robot
assembly time
(minutes)
10
9
8.6
7.8
6.6
7.5
6.8
7.4
8.9
8.8
9.2
7.6
9.3
6.9
7.8
7.9
8.8
8.7
6.7
8.9
9.4
8.8
9.7
6.8
9.7
6.7
7.7
8.5
8.6

Robot disassembly time
(minutes)
2.1
2.5
3.1
2.4
2.6
2.3
2.2
2.5
2.4
2.5
2.2
2.4
2.5
2.4
2.6
2.4
2.3
2.3
2.4
2.5
2.6
2.2
2.3
2.4
2.6
2.8
2.2
2.4
2.4

8.2

2.4
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The mean pre-operative time was 64.7 min. Mean
operating time for only unilateral salpingooophorectomy is 50.1 (SD 4.3) min, while only bilateral
salpingo-oophorectomy took 54.3 (SD 1.2) min. The
mean total operative time is 104.3 minutes which
includes the mean console time of 39.6 minutes plus
mean pre-op time of 64.7 minutes.

The lesions mostly are located in the pelvis and the
ovaries. Endometriomas varied in size from 3cms to
10cms with elevated CA 125 levels. They are subjected
to frozen section analysis (Figure 4) (frozen section).
There are adhesions between the ovaries and the pelvic
peritoneum, uterus and cul-de-sac. Scarring, puckering,
and hemosiderin staining of peritoneum is also noted.

The mean assembly time of robot is 8.2 min and the
dissembling time is 2.4 minutes. Mean estimated blood
loss is 40 ml; length of hospital stay is 1 day.

The patients with elevated CA125 levels were referred to
the oncology division with an anticipation of intraoperative difficulty and suspected ovarian cancer. In the
present study, the mean serum CA-125 level increased
when cases were associated with ovarian endometriomas
(Figure 5) (Endometrioma) consistent with findings from
most previous studies (Cheng et al., 2002).7

One case was converted to laparotomy. There was one
post-operative case with a complication of UTI and fever.
None of the cases needed blood transfusions. Postoperative pain relief was excellent by 8 weeks in 27
patients (93.1%).
We noticed that robotic route to manage endometriosis is
„visualize and manage‟ approach by which we see and
asses the difficulty of the surgery with regard to
(adhesions, pathology) and then perform robotic
technique best for the situation. Suturing was easier due
to the better 3D view of the surgical field. The entire
procedure is carried out with clarity and precision and
without surgeon‟s fatigue.
DISCUSSION
Endometriosis is a chronic inflammatory condition that
involves one or many areas of the pelvis, adnexa and
abdomen.4,5 Complete resection of endometriosis has
been traditionally considered a challenging operation,
even with operative laparoscopy. Robotic technology
provides exceptional visual feedback, enhanced surgical
ergonomics, and advanced instrumentation critical for
success of a difficult pelvic dissection.6
Review of literature on the application of Robotic surgery
to the treatment of Endometriosis showed only case
reports, series or short studies that documented the
experience of da vinci surgical system in stage 2 and 3
endometriosis. Nezhat et al. showed that robot assisted
laparoscopy could be successfully applied in stage 4
endometriosis.5
Most of the patients in the study group who underwent
hysterectomy for endometriosis (41%), had an initial
laparoscopy performed and they were diagnosed with
endometriosis. While gynecologists were able to clear
away much of the endometrial tissue at that time, they
were told that the endometriosis would come back and
they would need to have a hysterectomy within two or
three years. However, many didn't want to have major
surgery, and so endured the symptoms for years. Finally,
when they could no longer endure, with severe pain
affecting the quality of life, they turned to these operators
with a high level of expertise. They presented with fusion
of tissues causing cysts and scars.

Consistent with previous reports, we found both a lower
mean blood loss and minimal hospital stay in patients
managed robotically.8 This could be the result of 3D
vision and improved depth perception. Precision in the
surgery with the absence of tremor and the ergonomic
position, provides comfort for the surgeon. 9 We have not
experienced any major intra- and/or post-operative
complications in our procedures.
Roberta B. Ness et al. found that the odds of developing
ovarian cancer were 50% higher among women
diagnosed with endometriosis10 and another case-control
study by Brinton and colleagues also found a 2.5- to 3.5fold increase in endometrioid and clear cell tumors
among women with endometriosis.11 For the patients with
elevated CA 125 levels we discussed pre-operatively
about the possibility of robotic staging, peritoneal
washings, omentectomy and lymphadenectomy if ovarian
malignancy is found during surgery. None of them had
endometriosis related ovarian cancer.
The symptomatic women in the study who completed the
family and desired no more children underwent total
robot assisted laparoscopic hysterectomy with BSO,
whereas the Infertile women with recurrent endometriosis
following conservative surgery underwent Robot assisted
unilateral or bilateral salpingo-oophorectomy.
Recent studies have shown an extra time necessary for
preoperative setup in robotic cases as a specific factor
leading to longer operative times.12 Shorter OR times can
be achieved by any modification that can decrease pre-op
setup time.13,14 In our study the overall mean total
operative time was 104. 3 min which longer than
traditional laparoscopic cases, but compared to other
robotic procedural studies is significantly less. This is due
to the advanced laparoscopic skills of the operating
surgeons. According to Lenihan et al.15 the learning curve
for robotic-assisted surgeries is 50 cases.
A review of literature shows reduction in operative times
after the learning curve but little attention is given to the
OR team. Our preoperative times decreased from 76.9
min to 52.1 min with a mean preoperative time of 64.7
min and the operative time at the console was only 39.6
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minutes. This may be explained by the fact that all 170
cases were performed by both surgeons with the
assistance of high quality team cooperation. Using this
enhanced team coordination we had significantly
decreased preoperative setup time with a dependable OR
environment for patient safety. Our data is consistent
with previous studies as this seems to be the most costeffective utilization of the surgical robot in gynecological
procedures (Lasser MS, et al. 2012).16
The overall median estimated blood loss was 40 ml. No
patient received blood transfusion. There were no intra or
post-operative complications. One patient had postoperative fever attributed to UTI and her symptoms
resolved quickly with treatment. All of them had good
recovery and urine output. Catheter was removed as soon
as the patient was ambulant. The mean duration of
hospital stay was one day. All of the patients underwent
the robotic procedures successfully. They had less
postoperative pain hence less need for analgesics.
Endometriosis is often a difficult disease to treat as
recurrence rates are high. Studies quote that pain relief is
noted postoperatively in 50-95%. In a double blind
randomized study by Sutton et al, pain relief was
significant at one year.17 Post-surgical adhesions may
sometimes continue to be the cause of pain. Parker et al
stressed that surgical techniques have to be optimized at
reducing post-operative adhesions.18
We routinely used EVICEL® Fibrin Sealant (Human) for
general hemostasis as drip application after the procedure
Figure 6 (EVICEL® Fibrin Sealant).
When questioned about the pain and progress, one of the
patients on her first post-operative visit, whose extensive
condition required hysterectomy in her words says
“Robotic surgery is so much better, I know from
experience that it can be hard to get around for a couple
of weeks after traditional surgery, but after the robotic
procedure, I was moving in a couple of days. I felt better
right away, and was back to feeling like I could do
anything in just a couple of weeks. It's definitely the way
to go.” She is one of the many satisfied patients who felt
the similar way.
The success of surgery is highly dependent on the
expertise and training of the gynecological surgeon
performing the robotic procedure. Robotic application is
an acceptable safe alternative to traditional laparoscopy,
with minimal blood loss, quick recovery, shorter hospital
stay and no complications.
The limitations to our study include the retrospective,
observational experience design introducing the potential
for bias. However, review of literature on the roboticassisted approach to the management of stage 2 and 3
endometriosis demonstrates that our experience is
consistent with the data that is published.

View point
Whether a robot is truly justified in the gynec workforce
is a difficult question to answer because of equally
potential benefits and drawbacks. Undoubtedly it is a
superior tool in the surgical armamentarium and with it
also come the drawbacks of huge finances be it be the
initial cost or the maintenance of the equipment. But the
debate now seems to be settled for the benefits of robotic
surgeries.19,20 While discussing various options for
treatment, in my clinical practice, I would definitely
discuss robotic surgery as an option offered and explain
about the long-term outcomes.
Upon completion of my tenure, I was able to learn to
recognize techniques to prevent and repair intra-operative
complications, including genito-urinary and vascular
injuries, evaluate relevant indications, techniques, and
outcomes of robotic surgical procedures, review surgical
anatomy of the female pelvis and surgical dissection
techniques for complex hysterectomy, endometriosis,
myomectomy, and pelvic support procedures.
In reflecting on my experience, the most important thing
I‟ve learned is alike in the surgical techniques, though
diverse in the work infrastructure and latest technology,
East and West have common patient scenarios which can
be tackled with exchange of training opportunities. This
interchange of knowledge and skills will benefit both
countries with an increase in the patient safety and
surgeon‟s efficiency. So in this new age of technology
one has to be an increasingly sophisticated learner and
need to be associated with experienced surgeons to
become all the way, the seasoned professional.
CONCLUSION
This study is first of its kind to present an observational
experience of an Indian Obgyn fellow in USA and the
role of robot assisted laparoscopy in the management of
stage 2 and 3 endometriosis. The revolutionary surgical
robots in gynecology offer the promise of overcoming
many shortcomings of laparoscopy and numerous studies
have demonstrated to date the usefulness of Robotic
surgery in the treatment of pelvic endometriosis, thanks
to the technology and trained operating surgeons. This
article is a helpful addition in the ongoing literature of
robot assisted laparoscopy.
As of June 30, 2014, over 3,102 units were installed
worldwide with 2,153 units in the United States and the
use of robots continues to increase. University based
hospitals and community based institutions in US are
increasingly adopting the use of robot with Intuitive
surgicals providing the surgeon training in an academic
setting. Today, robotic technology enhanced our surgeries
with great precision, autonomy, and efficiency.
Tomorrow the younger generation with more
sophisticated skills in computers will see a different
world beyond what can be imagined or achieved today.
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Gynecologists who develop confidence and have
successful results in the treatment of endometriosis, as
they adapt to latest technology with the available data,
often prefer that method of surgery in the best interests of
the patients. We think it is our prime responsibility as
gynecologists is to critically evaluate these new
developments to ensure the best clinical outcomes to our
patients.
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